Showing results (51-60 of 99) with videos related to
Sort By:
Pageof 10
Revue Neurologique|December 11, 2021
Evaluation of the quality of the care pathway for patients with multiple sclerosis in France: Results of an original study of a cohort of 700 patientsD Veillard, E Le Page, J Epstein, et al.Clinical Genetics|September 1, 1983
An HLA-All association with the hemochromatosis allele?L Le Mignon, M Simon, R Fauchet, et al.Journal D'Urologie|January 1, 1994
[Urination disorders in multiple sclerosis: value of urodynamic assessment]P Gallien, M P Le Bot-Le Borgne, B Nicolas, et al.Neurology|September 26, 2002
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MSD Brassat, C Recher, E Waubant, et al.BMJ (Clinical Research Ed.)|February 11, 1989
Optimum duration of antithyroid drug treatment determined by assay of thyroid stimulating antibody in patients with Graves' diseaseG Edan, C Massart, B Hody, et al.Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|October 21, 2005
[Multiple sclerosis and physical activities]V Kerdoncuff, A Durufle, H Le Tallec, et al.Revue Neurologique|September 24, 2008
[Use of mitoxantrone in early multiple sclerosis with malignant disease course. Observational study in 30 patients with clinical and MRI outcomes after one year]S Ory, M Debouverie, E Le Page, et al.British Journal of Haematology|May 1, 1985
Is the HLA-linked haemochromatosis allele implicated in idiopathic refractory sideroblastic anaemia?M Simon, C Beaumont, J Briere, et al.Journal of Neurology|July 29, 2018
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patientsG Balloy, J Pelletier, L Suchet, et al.Neurology|April 13, 2005
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind studyB Stankoff, E Waubant, C Confavreux, et al.Pageof 10